1H-Indazol-5-ol Chemical Properties

Melting point:

186-191°C

Boiling point:

366.5±15.0 °C(Predicted)

Density 

1.434±0.06 g/cm3(Predicted)

storage temp. 

Inert atmosphere,Room Temperature

form 

powder to crystal

pka

9.22±0.40(Predicted)

color 

White to Light yellow

InChI

InChI=1S/C7H6N2O/c10-6-1-2-7-5(3-6)4-8-9-7/h1-4,10H,(H,8,9)

InChIKey

ZHDXWEPRYNHNDC-UHFFFAOYSA-N

SMILES

N1C2=C(C=C(O)C=C2)C=N1

CAS DataBase Reference

15579-15-4(CAS DataBase Reference)

Safety Information

Hazard Codes 

Xi,Xn

Risk Statements 

22-41

Safety Statements 

26-39

WGK Germany 

3

Hazard Note 

Irritant

HS Code 

2933998090

1H-Indazol-5-ol Usage And Synthesis

Uses

5-Hydroxy-1H-indazole is a possible Rho kinase inhibitor. It is also used to discover (sulfamoylphenyl)indazolyl acetamides and carboxamides as inhibitors of mitotic kinase TTK.

Synthesis

General procedure for the synthesis of 1H-indazol-5-ol using 5-methoxy-1H-indazole as starting material: a dichloromethane solution of boron tribromide (18.5 mL, 18.5 mmol) was slowly added dropwise to a solution of 5-methoxy-1H-indazole (1.24 g, 8.40 mmol) in dichloromethane (84 mL) at 0 °C. After the dropwise addition was completed, the reaction mixture was warmed to room temperature and stirred continuously for 10 hours. Upon completion of the reaction, the reaction solution was poured into an ice water bath and subsequently extracted with ethyl acetate. The organic phases were combined and washed sequentially with saturated aqueous sodium bicarbonate solution and saturated aqueous sodium chloride solution. The organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure to remove the solvent. The resulting crude product was purified by silica gel column chromatography (eluent: chloroform/methanol=96/4, v/v) to afford 1H-indazol-5-ol (877 mg, 71% yield) as a white solid. The structure of the product was confirmed by 1H-NMR (DMSO-d6): δ 6.88 (1H, dd, J = 8.8, 2.2 Hz), 6.96 (1H, d, J = 2.2 Hz), 7.34 (1H, d, J = 8.8 Hz), 7.84 (1H, s).

References

[1] Patent: EP1403255, 2004, A1. Location in patent: Page 44

1H-Indazol-5-ol(15579-15-4)Related Product Information

• Stanozolol
• Tebuconazole
• Cyproconazol
• Diniconazole
• Triadimenol
• CHLOROPHOSPHONAZO III
• Hexaconazole
• 5-Benzyloxy-1H-indazole-3-carboxylic acid
• METHYL 5-METHOXY-1H-INDAZOLE-3-CARBOXYLATE
• 5-TRIFLUOROMETHOXY-1H-INDAZOLE-3-CARBOXYLIC ACID
• 5-Methoxy-3-indazolecarboxylic acid
• 5-METHOXY-1H-INDAZOLE-3-CARBALDEHYDE
• 1H-INDAZOL-3-OL,1H-Indazol-3-ol ,97%
• 1-BENZYL-1H-INDAZOL-3-OL
• 1H-Indazol-4-ol ,97%
• 1H-INDAZOL-3-OL
• 5,6-DIMETHOXY-1H-INDAZOLE-3-CARBONITRILE
• 5,6-DIMETHOXY-1H-INDAZOLE